TickerFacts.

Translational Development Acquisition Corp. (TDAC): Operating Income

Annual figures by period end, from SEC filings.

-$944.5K
Year ended 2025-12-31
-$1.32M
Trailing 12 months to 2026-06-30
2023-12-31: -$485.6K2024-12-31: -$196.4K2025-12-31: -$944.5K-$944.5K
2023-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$944.5Kn/m2026-03-30, From 2025-01-01
2024-12-31-$196.4Kn/m2026-03-30, From 2024-01-01
2023-12-31-$485.6Kn/a2025-03-31, From 2023-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Blank Checks), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Translational Development Acquisition Corp. (TDAC)2025-12-31-$944.5Kn/m
Newbury Street II Acquisition Corp (NTWO)2025-12-31-$688.5Kn/a
Copley Acquisition Corp (COPL)2025-12-31-$479.7Kn/a
1RT Acquisition Corp. (ONCH)2025-12-31-$474.5Kn/a
Dynamix Corp (DYNC)2025-12-31-$5.41Mn/a
Twelve Seas Investment Co III/Cayman (TWLV)2025-12-31-$229.3Kn/a
Oaktree Acquisition Corp. III Life Sciences (OACC)2025-12-31-$1.20Mn/a
Thayer Ventures Acquisition Corp II (TVAI)2025-12-31-$1.04Mn/a
Cantor Equity Partners I, Inc. (CEPO)2025-12-31-$973.6Kn/m

Compare TDAC, NTWO, COPL, ONCH side by side · Screen every company in Blank Checks ↗